Cetera Investment Advisers Chimerix Inc Transaction History
Cetera Investment Advisers
- $44.2 Billion
- Q3 2024
A detailed history of Cetera Investment Advisers transactions in Chimerix Inc stock. As of the latest transaction made, Cetera Investment Advisers holds 12,972 shares of CMRX stock, worth $45,272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,972
Previous 13,972
7.16%
Holding current value
$45,272
Previous $12,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CMRX
# of Institutions
70Shares Held
37MCall Options Held
52.7KPut Options Held
130K-
Ra Capital Management, L.P. Boston, MA8.8MShares$30.7 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.33MShares$15.1 Million0.0% of portfolio
-
Monaco Asset Management Sam4.22MShares$14.7 Million0.58% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.4MShares$8.36 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.21MShares$7.71 Million0.03% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $306M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...